Authors:
, , , , , , , , , , , , , , , , , and
Past two years | Past Year | Past 30 Days | |
---|---|---|---|
Abstract Views | 155 | 111 | 9 |
Full Text Views | 509 | 11 | 0 |
PDF Downloads | 46 | 9 | 2 |
Chloroquine retinopathy (CR) is a major complication of long-term malaria prophylaxis (LTMP) causing permanent visual dysfunction and occasionally blindness. After an extensive review of the published accounts of CR, we concluded that the risk of retinopathy in subjects receiving LTMP is limited to a cumulative dose that does not exceed 140 g. We present a case of CR that occurred after 8 years of malaria prophylaxis with chloroquine at a cumulative dose of 125 g. Because a threshold dose of chloroquine for retinal toxicity has not been established, careful, ongoing screening is required, especially as the cumulative dose increases.
Past two years | Past Year | Past 30 Days | |
---|---|---|---|
Abstract Views | 155 | 111 | 9 |
Full Text Views | 509 | 11 | 0 |
PDF Downloads | 46 | 9 | 2 |